Hirokazu Okada

12.4k citations
220 papers · 8.9k · 3 hit papers · h-index 36

Impact in

  • Nephrology top 0.1%
    • Chronic Kidney Disease and Diabetes
    • Renal Diseases and Glomerulopathies
    • Dialysis and Renal Disease Management
  • Genetics top 2%

Papers in

    • Renal Diseases and Glomerulopathies 48
    • Chronic Kidney Disease and Diabetes 40
    • Dialysis and Renal Disease Management 32
    • Blood Pressure and Hypertension Studies 22
    • Renin-Angiotensin System Studies 13

Hirokazu Okada

212 papers receiving 8.7k citations

Hirokazu Okada's Hit Papers

Evidence that fibroblasts derive from epithelium during tissue fibrosis 2002 · 1.6k citations
1.6k0+10+20Years since publication50010001.5k

Peers

Hirokazu Okada
Comparison fields: 5 of 138
  • Nephrology 2.8k
  • Genetics 579
  • Cardiology and Cardiovascular Medicine 1.2k
  • Pulmonary and Respiratory Medicine 1.7k
  • Molecular Biology 3.4k
Replace Shuei‐Liong Lin with:
Shuei‐Liong Lin Taiwan
George F. Schreiner United States
Masayuki Iwano Japan
Nancy A. Noble United States
Xiao Ru Huang Hong Kong
Katherine Gordon United States
Yusuke Suzuki Japan
Theodore M. Danoff United States
Jeremy Hughes United Kingdom
Frank Eitner Germany
Hirokazu Okada relative to Shuei‐Liong Lin Taiwan Shuei‐Liong Lin's profile →
Citations per field
00.5×1.5×
Shuei‐Liong Lin · 1×
Citations per year

Countries citing papers authored by Hirokazu Okada

Since Specialization
Citations

This map shows the geographic impact of Hirokazu Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Okada more than expected).

Fields of papers citing papers by Hirokazu Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokazu Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Okada. The network helps show where Hirokazu Okada may publish in the future.

Co-authors

The 25 scholars most cited alongside Hirokazu Okada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hirokazu Okada Line = papers co-authored together Hirokazu Okada links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 220 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Evidence that fibroblasts derive from epithelium during tissue fibrosis
Hit paper breakdown →
20021558
2
Evidence that fibroblasts derive from epithelium during tissue fibrosis
Hit paper breakdown →
20021355
3
Identification and characterization of a fibroblast marker: FSP1.
Hit paper breakdown →
1995894
4 1997376
5 2004349
6 2011280
7 2012183
8 2004155
9 1997138
10 2004131
11 2002129
12 2002114
13 200196
14 200193
15 199587
16 201484
17 202071
18 201165
19 200761
20 200560

About Hirokazu Okada

Hirokazu Okada is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 220 papers that have together received 8.9k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (48 papers), Chronic Kidney Disease and Diabetes (40 papers), Dialysis and Renal Disease Management (32 papers), Blood Pressure and Hypertension Studies (22 papers), Renin-Angiotensin System Studies (13 papers), Renal and Vascular Pathologies (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Connective Tissue Growth Factor Research (9 papers). The work is most often cited by research in Nephrology (2.8k citations), Genetics (579 citations), Cardiology and Cardiovascular Medicine (1.2k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Molecular Biology (3.4k citations). Hirokazu Okada has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Eric G. Neilson, Theodore M. Danoff, Masayuki Iwano, Chengsen Xue, David Plieth, Yoshihiko Kanno, Hiromichi Suzuki, Raghu Kalluri, Tsutomu Inoue and Hiromichi Suzuki. Their work appears in journals such as Kidney International, Scientific Reports, American Journal of Kidney Diseases, Journal of the American Society of Nephrology and Clinical and Experimental Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact